Skip to content

JML PHARMA

Active Risk: moderate
General partnershipfounded 2024active for 2 yearsRiddersdal 15, 3090 Overijse, BelgiumKBO/BCE: BE 1010.591.035
Summary

The computed 12-month bankruptcy probability of JML PHARMA is 2.1% (moderate). The company has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. No annual accounts have been filed with the National Bank.

Register details

Identification
Legal formGeneral partnership
Founded21-06-2024
Activities, NACEBEL 2025
47730Retail sale of pharmaceutical products
29320Manufacture of motor vehicles, trailers and semi-trailers
Contact
E-mail jm_lambinet@yahoo.fr
E-invoicing
Reachable via Peppol
Peppol ID 0208:1010591035
Registered 13-10-2025

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 14 October 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.

Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.

Sites & property

Location & real-estate footprint
Registered office, Overijse · 1 establishment unit since 2024
registered office establishment The establishment unit on the map
Ground area
831 m²
Building footprint
165 m²
Building volume
1,071 m³
Parcel 23062M0583/00X002, Flanders · tallest building 8.1 m. Linked by address, not a title deed.
1 establishment unit
JML PHARMA
Riddersdal 15, 3090 OverijseRetail trade
since 2024unit no. 2.361.309.305
1 parcel
Flanders 1 (100%)
Cadastral parcel Region Area Buildings Height / floors
23062M0583/00X002 Flanders 831 m² 1 · 165 m² 8.1 m · 2
How the parcels are linked
Good to know
The parcel matches the address exactly.